Jolie Ringash

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.2K citations

Radiation Therapy, Medicine, Nasopharyngeal Cancer +8

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Alexis Bujold, Christine Massey, John J. Kim et al. · Journal of Clinical Oncology · 2013 · 820 citations · Full text

Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis

Brian O’Sullivan, Shao Hui Huang, Lillian L. Siu et al. · Journal of Clinical Oncology · 2013 · 585 citations · Full text

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Mark Lee, John J. Kim, Robert Dinniwell et al. · Journal of Clinical Oncology · 2009 · 476 citations

Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus–Related Oropharyngeal Carcinomas

Shao Hui Huang, Wei Xu, John Waldron et al. · Journal of Clinical Oncology · 2015 · 395 citations · Full text